Pharmacyte Biotech Inc's Comment on Sales, Marketing and Customers
The company relies on Austrianova as its sole manufacturer for product candidates, specifically handling the encapsulation process of cells for oncology applications. Austrianova is responsible for procuring all necessary raw materials, including cellulose sulfate, used in the proprietary encapsulation process. The company licenses technology and trademarks related to live cell encapsulation and the treatment of solid cancerous tumors. Customers and market segments mentioned include Austrianova and SG Austria.
PharmaCyte Biotech Invests $7 Million in MyMD Pharmaceuticals to Develop Novel Therapies for Inflammatory DiseasesPharmaCyte Biotech, a renowned biotechnology company specializing in cellular therapies for various diseases, has made a strategic investment of $7 million in MyMD Pharmaceuticals, a clinical-stage biopharmaceutical company focused on addressing age-related diseases, autoimmune disorders, and inflammatory conditions. This investment highlights the strong commitment of both companies to advancing innovative treatments for patients suffering from these challenging health ailments.The announcement of this investment comes on the heels of MyMD s impressive results from a Phase 2 clinical trial of its...
Pharmacyte Biotech Inc’s Comment on Sales, Marketing and Customers
The company relies on Austrianova as its sole manufacturer for product candidates, specifically handling the encapsulation process of cells for oncology applications. Austrianova is responsible for procuring all necessary raw materials, including cellulose sulfate, used in the proprietary encapsulation process. The company licenses technology and trademarks related to live cell encapsulation and the treatment of solid cancerous tumors. Customers and market segments mentioned include Austrianova and SG Austria.
Sources:
Pharmacyte Biotech Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Pharmacyte Biotech Inc’s corporate clients.
For your research, we’ve provided 9 tables on Pharmacyte Biotech Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
